Why support research at the University of Michigan Rogel Cancer Center?
Cancer research is an investment in a healthier future. Every dollar devoted to scientific research has the potential to transform the cancer landscape for today's patients as well as tomorrow's.
Although large-scale publicly funded research is essential to advancing medical science, it is private donors who are responsible for planting the seeds of discovery. No institution is more successful in obtaining federal grant funding for cancer research than Michigan. What's behind that success rate? Private donor support. The reality of research funding is that, before even one grant dollar is awarded, investigators need to conduct preliminary studies to confirm that the ideas they are pursuing have merit. That "seed money" comes from private philanthropy. Our track record in leveraging private gifts into grants speaks for itself: on average, one dollar of private support for U-M cancer research generates $20 in grant funding. Learn how your gift can generate this impressive return on investment.
The University of Michigan Rogel Cancer Center has a distinguished history of scientific excellence, collaboration and impact in basic science, clinical research and cancer control research. Through our focus on team science and research excellence, we aim to be a national leader in prevention, early diagnosis, optimal treatment and survivorship care for those at risk of or affected by cancer. Our mission is to reduce cancer burden and improve cancer outcomes through research, innovation, collaboration, education, outreach and engagement.
Collaboration Leads to Scientific Breakthroughs
Our members, including clinicians, researchers and other scientists, maintain a very collaborative relationship across all areas of the University of Michigan Rogel Cancer Center. Encompassing members from 53 departments across 9 University of Michigan schools, we are harnessing the power of one of the largest, most robust and highly esteemed research universities in the world to create new knowledge about cancer.
Our Research Portfolio
Cancer Control and Population Sciences
Translational and Clinical Research
Basic Science Division